Detalles de la búsqueda
1.
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Breast Cancer Res
; 25(1): 39, 2023 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046348
2.
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Mod Pathol
; 35(10): 1362-1369, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729220
3.
A simple digital image analysis system for automated Ki67 assessment in primary breast cancer.
Histopathology
; 79(2): 200-209, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590538
4.
Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Breast Cancer Res
; 22(1): 14, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005287
5.
Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Breast Cancer Res
; 21(1): 135, 2019 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801615
6.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology
; 75(2): 225-235, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31017314
7.
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.
Breast Cancer Res
; 19(1): 16, 2017 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28183321
8.
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
Breast Cancer Res
; 18(1): 39, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27036195
9.
An international study to increase concordance in Ki67 scoring.
Mod Pathol
; 28(6): 778-86, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25698062
10.
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
Nat Commun
; 14(1): 4017, 2023 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37419892
11.
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.
Breast Cancer Res
; 14(2): R57, 2012 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22475046
12.
Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors.
Clin Cancer Res
; 25(24): 7485-7496, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31548345
13.
The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.
Clin Cancer Res
; 24(19): 4763-4770, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891724
14.
Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study.
J Clin Pathol
; 69(2): 128-35, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26281860
15.
High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.
J Pathol Clin Res
; 2(3): 138-53, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27499923
16.
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.
NPJ Breast Cancer
; 2: 16014, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28721378
17.
"Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring.
Hum Pathol
; 46(11): 1694-704, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26410019
18.
Who would have thought a single Ki67 measurement would predict long-term outcome?
Breast Cancer Res
; 11 Suppl 3: S15, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20030866
19.
Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistry.
Cytometry B Clin Cytom
; 56(1): 55-61, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14582137
20.
Factors predicting late recurrence for estrogen receptor-positive breast cancer.
J Natl Cancer Inst
; 105(19): 1504-11, 2013 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24029245